Sol-Gel Technologies

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLGL and other ETFs, options, and stocks.

About SLGL

Sol-Gel Technologies Ltd. is a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T.

CEO

Alon Seri-Levy

CEOAlon Seri-Levy

Employees

Employees53

Headquarters

Ness Ziona, Tel Aviv

HeadquartersNess Ziona, Tel Aviv

Founded

1997

Founded1997

Employees

Employees53

SLGL Key Statistics

Market cap

115.65M

Market cap115.65M

Price-Earnings ratio

12.06

Price-Earnings ratio12.06

Dividend yield

—

Dividend yield—

Average volume

6.19K

Average volume6.19K

High today

$5.80

High today$5.80

Low today

$4.75

Low today$4.75

Open price

$5.80

Open price$5.80

Volume

41.50K

Volume41.50K

52 Week high

$10.00

52 Week high$10.00

52 Week low

$3.94

52 Week low$3.94

SLGL News

Simply Wall St 6d

Are Strong Financial Prospects The Force That Is Driving The Momentum In Sol-Gel Technologies Ltd.'s NASDAQ:SLGL) Stock? - Yahoo Finance

Sol-Gel Technologies (NASDAQ:SLGL) has had a great run on the share market with its stock up by a significant 20% over the last three months. Given the company'...

SLGL Earnings

-$0.47

-$0.11

$0.25

$0.61

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 10, Pre-Market

ActualExpected Nov 10, Pre-Market